<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-165238</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Laboratory surveillance of Salmonella enterica from human clinical cases in Colombia 2005-2011</dc:title>
<dc:description xml:lang="en">Introduction: Salmonella is an enteropathogen acquired through contaminated food or water. In Colombia, Salmonella spp. is included in the national surveillance of Acute Diarrhoeal Diseases and typhoid fever initiated in 1997. This report shows the phenotype and genotype results obtained from 2005 to 2011. Methods: A total of 4010 isolates of Salmonella enterica were analysed by serotyping with Kauffmann-White-LeMinor, antimicrobial resistance patterns, and pulse-field gel electrophoresis (PFGE). Results: A total of 93 serovars were identified, of which, Typhimurium, Enteritidis, Typhi, Dublin, Panama, Derby, Braenderup, Saintpaul, and Uganda were prominent. The highest levels of resistance were found for tetracycline and nalidixic acid. Susceptibility was observed in 52.4% (2101/4010) of the isolates. Multi-resistance was recorded in 54.9% of Typhimurium isolates, with 81 different combinations. Using PFGE, 51.9% (2083/4010) isolates were analysed in 34 serovars, and 828 electrophoretic patterns were obtained. From these, 8 patterns were found in at least two Latin-American countries. Conclusion: The surveillance of Salmonella spp. provides information on the serovar distribution, antimicrobial resistance, and clonal distribution in Colombia, as well as information to treat this disease and control the spread of antimicrobial bacterial resistance (AU)</dc:description>
<dc:creator>Bautista, Adriana</dc:creator>
<dc:creator>Wiesner, Magdalena</dc:creator>
<dc:creator>Catering Rodríguez, Edna</dc:creator>
<dc:creator>Díaz Guevara, Paula</dc:creator>
<dc:creator>Moreno, Jaime</dc:creator>
<dc:creator>Realpe, María Elena</dc:creator>
<dc:creator>Gaspera, Anabella della</dc:creator>
<dc:creator>Montaño, Lucy</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Salmonella spp. es un enteropatógeno que se transmite a los humanos a través de alimentos o agua contaminada. En 1997, el Grupo de Microbiología del Instituto Nacional de Salud de Colombia inició el programa de vigilancia de enfermedad diarreica aguda y fiebre tifoidea, que incluye Salmonella spp. Este informe presenta los resultados fenotípicos y genotípicos de los aislamientos recuperados de 2005 a 2011 como parte de la vigilancia. Métodos: Un total de 4.010 aislamientos de Salmonella spp. fueron analizados por serotipificación con el esquema Kauffmann-White-LeMinor, patrones de sensibilidad antimicrobiana y de electroforesis en gel de campos pulsados (PFGE). Resultados: Se identificaron un total de 93 serovares, con 9 predominantes, Typhimurium, Enteritidis, Typhi, Dublin, Panama, Derby, Braenderup, Saintpaul y Uganda. Salmonella spp. presentó altos porcentajes de resistencia a tetraciclina y ácido nalidíxico. El 52,4% (2.101/4.010) de los aislamientos fueron sensibles a todos los antibióticos. La multirresistencia se observó en el 54,9% de los aislamientos de Typhimurium, representada por 81 combinaciones. Por PFGE se analizaron 51,9% aislamientos (2.083/4.010) de 34 serovares, generando 828 patrones electroforéticos XbaI. De estos, 8 se reportaron en al menos 2 países en Latinoamérica. Conclusión: La vigilancia de Salmonella spp. permite conocer la distribución de los serovares, su resistencia y la identificación de clones endémicos en Colombia, aportando bases para un tratamiento óptimo en las infecciones generadas por este patógeno y en el diseño de programas para disminuir la dispersión de aislamientos multirresistentes (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;35(7): 417-425, ago.-sept. 2017. ilus, tab, mapas</dc:source>
<dc:identifier>ibc-165238</dc:identifier>
<dc:title xml:lang="es">Vigilancia por laboratorio de Salmonella enterica en casos clínicos humanos en Colombia 2005 a 2011</dc:title>
<dc:subject>^d30142^s22045</dc:subject>
<dc:subject>^d28441^s22066</dc:subject>
<dc:subject>^d12857^s22080</dc:subject>
<dc:subject>^d3994^s22046</dc:subject>
<dc:subject>^d33154^s22054</dc:subject>
<dc:subject>^d33283^s22001</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24312^s22045</dc:subject>
<dc:subject>^d3137^s22080</dc:subject>
<dc:subject>^d12862^s22001</dc:subject>
<dc:subject>^d12863^s22001</dc:subject>
<dc:subject>^d12854^s22001</dc:subject>
<dc:type>article</dc:type>
<dc:date>201709</dc:date>
</metadata>
</record>
</ibecs-document>
